Leptin Levels in Papillary Thyroid Cancer

Completed

• Conditions: Leptin Levels; Thyroid Cancer, Papillary

• Registration Number: NCT01659385
• Lead Sponsor: University of Nebraska

Brief Summary

The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

Detailed Description

There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.

Study Timeline

• Study First Submitted: 2012-08-03
• Study First Submitted QC: 2012-08-06
• Study Start: 2012-08-07
• Study First Posted: 2012-08-07
• Primary Completion: 2013-04-25
• Study Completion: 2013-04-25
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-31
• Last Update Posted: 2023-09-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 18

Inclusion Criteria

• Female
• Age>/- 19
• Not currently pregnant or lactating
• Normal thyroid gland by history

Exclusion Criteria

• Male Gender
• Pregnancy
• Lactation
• Age below 19
• Abnormal thyroid gland by history
• Abnormal thyroid gland by structure using ultrasound
• Abnormal thyroid gland by function using TSH, Free T4

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.	During Study	Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.

Trial Locations

Locations (1)

University of Nebraska Medical Center; 🇺🇸 Omaha, Nebraska, United States